Tissue Surgery Articles & Analysis
25 news found
Introduction Intraoperative irrigation is a commonly used method aimed at reducing microbial burden by removing tissue debris, metabolic waste, and tissue exudate from the surgical field prior to site closure.1 With the absence of universally established standard of care and robust clinical data, the selection of appropriate irrigation solution remains a topic of debate. Isotonic saline has ...
Active Implants, LLC, a company that develops orthopedic implant solutions, today announced enrollment of the 100th patient in clinical trials evaluating the NUsurface® Meniscus Implant for the treatment of persistent knee pain caused by injured or deteriorating meniscus tissue. The surgery was performed by orthopedic surgeon Dr. Wayne Gersoff of Advanced ...
The honeycomb lens technology refocuses each laser beam, allowing the skin tissue to extensively and intensively stimulate the fibroblast response under high energy concentration. ...
Reveal Surgical is working on changing that reality through its new, AI-based Sentry technology, which leverages a combination of AI and Raman spectroscopy to provide real-time tissue diagnostics during surgery for otherwise-invisible tumors. Raman spectroscopy is the use of light scattering from a laser to detect molecular structures and compositions of a ...
Hominis requires a much smaller footprint and costs significantly less than conventional robotic systems, making it possible for more hospitals and ambulatory surgery centers to acquire the system and offer more patients the benefits of less invasive robotic surgery. ...
The newest ISU features expand upon these capabilities and introduce more advanced features including: 3D measurement, digital tagging, image enhancement, and enhanced camera control based on real-time data from anatomical structures while performing surgery. This will be the first time any of these features will be clinically available in soft-tissue abdominal ...
Bio-Tissue, Inc., a TissueTech company and pioneer in the clinical application of human birth tissue allografts to promote regenerative healing for ocular surface disease and disorders, announced today that it has entered into a Vendor Agreement with EyePro Group Purchasing Organization (GPO), LLC. As such, GPO members can now take advantage of membership purchasing volume discounts to access ...
Fibroids are treated from within the uterus, so treatment with the Sonata System requires no incisions, no tissue is surgically removed, and the uterus is retained. “We are incredibly fortunate to have advocates like Dr. ...
Fibroids are treated from within the uterus, so treatment with the Sonata System requires no incisions, no tissue is surgically removed, and the uterus is retained. “Gynesonics has a long and successful history of meaningful innovation, and changes that have real benefits to the healthcare system and to the patient. ...
Fibroids are treated from inside the uterus, so the Sonata Treatment requires no incisions, no tissue is surgically removed, and the uterus is preserved. Anthem is one of the country’s largest healthcare insurance plans and this policy validates the need for less invasive treatment options for women with systematic fibroids. Currently in the U.S. women will wait 3-5 years ...
Redwood City, CA, August 11, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today a group of 12 surgeons from multiple fibroid treatment centers in Germany, Austria and Switzerland have published a review of symptomatic fibroid treatments, and recommended a treatment algorithm ...
Fibroids are treated from inside the uterus, so the Sonata Treatment requires no incisions, no tissue is surgically removed, and the uterus is preserved. “This is a great decision by Florida Blue that recognizes the importance of offering this minimally invasive option to women. ...
Fibroids are treated from within the uterus, so treatment with the Sonata System requires no incisions, no tissue is surgically removed, and the uterus is retained. “The Cigna policy covering transcervical fibroid ablation will make a significant difference to millions of women seeking treatment for their symptomatic fibroids and is aligned with the recent ACOG Practice ...
“Understanding a patient’s gene expression within atherosclerotic plaque may provide novel prognostic insights. This typically would require tissue biopsy or surgery, which is not feasible for most patients,” said Dr. ...
ByElucid
Memic, a medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, today announced that the U.S. ...
IMPACT Lourdes members voted to award $30,000 to purchase the MarginProbe system, equipment that assists in detecting cancerous breast tissue. With MarginProbe, surgeons can assess breast tissue in the operating room to give them greater confidence that they successfully removed all the cancer in the first lumpectomy surgery. ...
” The presence of positive margins is a significant challenge in breast-conserving surgery. Positive surgical margins occur when post-operative pathology indicates cancer cells are present at the edge of removed tissue, indicating that not all the malignant tissue was removed during an operation. ...
Polyganics’ easy-to-use device is made of the Company’s synthetic and safe bioresorbable polymers and optimized to effectively adhere to and seal-off the surgically treated tissue throughout the critical healing period after hepato-pancreato-biliary (HPB) surgery. ...
ByRegenity
SGM-101 is being developed to provide cancer surgeons with a novel intraoperative imaging tool that enables them to visualize tumor tissues overexpressing CEA in real-time during surgery. This allows surgeons to more clearly delineate the margin between tumor tissue and healthy tissue, enabling a more accurate and complete ...
BySurgiMab
” Its use is made simple with the addition of Sonavex’s EchoMark bioresorbable markers for marking soft tissue sites in surgical patients. Cleared by the FDA last year, the highly echogenic, resorbable polymeric implants eliminate the need for expertise in ultrasound to measure blood flow. ...